A randomized, double-blind, parallel control study to evaluate the biosimilarity of QL1209 with Perjeta® in healthy male subjects

Overview of attention for article published in Frontiers in Pharmacology, August 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,739 followers.

New Research: A randomized, double-blind, parallel control study to evaluate the biosimilarity of QL1209 with Perjeta® in healthy male subjects https://t.co/uEkDY5jsu3 #pharmacology

23 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.